HIV/AIDS Research
Dynamics of HIV replication related to timing of ritonavir administration
Published in AIDS Weekly, September 13th, 2004
According to recent research published in the Journal of Medical Virology, "Using a system that allows transfection of resting peripheral blood lymphocytes (PBLs) two questions were addressed: the kinetics of HIV replication from the state of proviral latency, and the impact of different parameters on the efficacy of protease inhibitors to control HIV replication."
"PBLs were transfected with an infectious full length HIV-DNA harboring a luciferase reporter gene and activated thereafter. Ritonavir was added at different times at doses ranging from to 0.06 to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-09-13)
More Articles from AIDS Weekly
- Antiretroviral Therapy
Specific genotype correlates with high plasma efavirenz levels in HIV patients - HIV/AIDS Exposure
New guidelines maximize effects of occupational HIV post-exposure prophylaxis - HIV/AIDS Pathogenesis
HIV-1 evolution/immunological responses similar at 10 years despite therapies - HIV/AIDS Research
Non-drug-associated mutations different between plasma and vaginal HIV - AIDS/HIV Vaccine
Camelized VH intrabodies against vif neutralize HIV-1 infectivity - AIDS/HIV Vaccine
Prospects for an AIDS vaccine explored - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
